According to Edward Dowd on Twitter, Naomi Wolf and her team’s review of Pfizer papers highlighted significant concerns regarding the effects of the vaccine on women. Dowd suggests that if these findings are confirmed in humans, it could lead to major demographic shifts, which may trigger regulatory responses against vaccine manufacturers. For traders, this development has the potential to impact pharmaceutical stocks such as Pfizer, with possible spillover effects on broader health sector equities. Additionally, heightened regulatory scrutiny and negative sentiment can influence investor risk appetite, leading to capital rotation into safe-haven assets including certain cryptocurrencies like Bitcoin. (Source: Edward Dowd via Twitter, May 13, 2025)